全文获取类型
收费全文 | 31348篇 |
免费 | 2610篇 |
国内免费 | 687篇 |
专业分类
耳鼻咽喉 | 238篇 |
儿科学 | 1280篇 |
妇产科学 | 778篇 |
基础医学 | 1766篇 |
口腔科学 | 908篇 |
临床医学 | 3642篇 |
内科学 | 6502篇 |
皮肤病学 | 405篇 |
神经病学 | 1328篇 |
特种医学 | 786篇 |
外国民族医学 | 1篇 |
外科学 | 2936篇 |
综合类 | 4207篇 |
现状与发展 | 1篇 |
预防医学 | 4839篇 |
眼科学 | 334篇 |
药学 | 2258篇 |
36篇 | |
中国医学 | 1145篇 |
肿瘤学 | 1255篇 |
出版年
2024年 | 149篇 |
2023年 | 886篇 |
2022年 | 1709篇 |
2021年 | 2187篇 |
2020年 | 1871篇 |
2019年 | 1716篇 |
2018年 | 1698篇 |
2017年 | 1262篇 |
2016年 | 1169篇 |
2015年 | 1104篇 |
2014年 | 2324篇 |
2013年 | 2183篇 |
2012年 | 1826篇 |
2011年 | 1975篇 |
2010年 | 1594篇 |
2009年 | 1520篇 |
2008年 | 1402篇 |
2007年 | 1436篇 |
2006年 | 1031篇 |
2005年 | 938篇 |
2004年 | 726篇 |
2003年 | 609篇 |
2002年 | 419篇 |
2001年 | 399篇 |
2000年 | 277篇 |
1999年 | 269篇 |
1998年 | 213篇 |
1997年 | 202篇 |
1996年 | 173篇 |
1995年 | 169篇 |
1994年 | 158篇 |
1993年 | 122篇 |
1992年 | 133篇 |
1991年 | 116篇 |
1990年 | 89篇 |
1989年 | 80篇 |
1988年 | 55篇 |
1987年 | 63篇 |
1986年 | 47篇 |
1985年 | 58篇 |
1984年 | 57篇 |
1983年 | 42篇 |
1982年 | 39篇 |
1981年 | 33篇 |
1980年 | 28篇 |
1979年 | 17篇 |
1978年 | 22篇 |
1977年 | 14篇 |
1976年 | 15篇 |
1975年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
放射性核素阴囊血池显像技术诊断精索静脉曲张的临床研究 总被引:1,自引:0,他引:1
目的:探讨放射性核素阴囊血池显像(RSI)技术诊断精索静脉曲张(VC)的价值。方法:本组126例有男性不育1年以上病史、精液分析异常的患者分别接受临床体格检查(PE);RSI技术检查,计算两侧阴囊血池指数值(SBPI),并观察是否有精索静脉血液返流;以及彩色双功能多普勒显像(CDFI)检查,对VC进行分型、定度。将PE,RSI结果分别与CDFI结果对比。结果:PE、RSI诊断VC的灵敏度分别为:71.7%、96.5%,特异度分别为:69.1%、97.1%。RSI诊断VC的灵敏度、特异度均高于PE。结论:RSI技术是诊断临床型、亚临床型VC的简单、安全、有效的无创诊断方法,也是一种非侵袭性,更加客观、准确地诊断VC的有效方法。 相似文献
92.
N R Hill P C Hindmarsh R J Stevens I M Stratton J C Levy D R Matthews 《Diabetic medicine》2007,24(7):753-758
AIM: As the practice of multiple assessments of glucose concentration throughout the day increases for people with diabetes, there is a need for an assessment of glycaemic control weighted for the clinical risks of both hypoglycaemia and hyperglycaemia. METHODS: We have developed a methodology to report the degree of risk which a glycaemic profile represents. Fifty diabetes professionals assigned risk values to a range of 40 blood glucose concentrations. Their responses were summarised and a generic function of glycaemic risk was derived. This function was applied to patient glucose profiles to generate an integrated risk score termed the Glycaemic Risk Assessment Diabetes Equation (GRADE). The GRADE score was then reported by use of the mean value and the relative percent contribution to the weighted risk score from the hypoglycaemic, euglycaemic, hyperglycaemic range, respectively, e.g. GRADE (hypoglycaemia%, euglycaemia%, hyperglycaemia%). RESULTS: The GRADE scores of indicative glucose profiles were as follows: continuous glucose monitoring profile non-diabetic subjects GRADE = 1.1, Type 1 diabetes continuous glucose monitoring GRADE = 8.09 (20%, 8%, 72%), Type 2 diabetes home blood glucose monitoring GRADE = 9.97 (2%, 7%, 91%). CONCLUSIONS: The GRADE score of a glucose profile summarises the degree of risk associated with a glucose profile. Values < 5 correspond to euglycaemia. The GRADE score is simple to generate from any blood glucose profile and can be used as an adjunct to HbA1c to report the degree of risk associated with glycaemic variability. 相似文献
93.
精神分裂症患者氯氮平使用现况调查 总被引:2,自引:0,他引:2
目的:了解精神分裂症患者氯氮平的使用现状。方法:按一定的抽样比例,抽取10个省市46家专科医院或综合医院精神科,于2002年4月22日至24日,采用自制问卷对4779例门诊和住院精神分裂症患者进行氯氮平使用情况调查。结果:39.0%(1863/4779)的患者使用氯氮平治疗,平均剂量为(216±133)mg/d;其中41.2%的患者为联合用药,合并使用抗胆碱能药物者为19.2%。与未使用氯氮平的患者比较,使用氯氮平的患者病程较长、家庭收入较低;男性及住院患者更多使用氯氮平,氯氮平治疗者疗效指数低于非氯氮平治疗者。患者的性别、就诊部门、家庭收入和是否首次住院以及抑郁和攻击症状为是否使用氯氮平治疗的影响因素。结论:精神分裂症患者氯氮平使用率为39.0%,其中41.2%为联合用药。是否使用氯氮平治疗与患者的经济状况和临床特征等因素有关。 相似文献
94.
95.
目的探讨孕妇不同孕期凝血指标变化趋势的数学模型及凝血指标异常变化的警戒值估计,帮助临床医生及预防保健人员及早期发现高危人群,有效预防产科出血和凝血并发症的发生。方法对214例孕妇的孕期凝血指标进行回顾性追索,根据聚类分析的结果,建立方差分析、回归分析及ARIMA时间序列分析模型,比较各检测指标在不同孕期的变化规律。结果所建模型均能够很好的模拟不同孕期凝血指标的变化规律,结果显示:PLT指标值在孕晚期出现明显的下降(P0.05),PT与INR指标值在妊娠中期的下降明显(P0.01),APTT在整个妊娠期均下降(P0.01),FG指标值在妊娠晚期出现上升(P0.01),不同孕期凝血指标的警戒值表达式为:μ±2σ。结论所建模型能够较好的模拟不同孕期凝血指标变化规律,不同孕期凝血指标的正常参考值范围及异常警戒值具有一定的医学应用价值。 相似文献
96.
Henrik Hein Lauridsen Jan Hartvigsen Claus Manniche Lars Korsholm Niels Grunnet-Nilsson 《European spine journal》2006,15(11):1717-1728
In studies evaluating the efficacy of clinical interventions, it is of paramount importance that the functional outcome measures are responsive to clinically relevant change. Knowledge thereof is in fact essential for the choice of instrument in clinical trials and for clinical decision-making. This article endeavours to investigate the sensitivity, specificity and clinically significant improvement (responsiveness) of the Danish version of the Oswestry disability index (ODI) in two back pain populations. Two hundred and thirty three patients with low back pain (LBP) and/or leg pain completed a questionnaire booklet at baseline and 8 weeks follow-up. Half of the patients were seen in the primary (PrS) and half in the secondary sectors (SeS) of the Danish Health Care System. The booklet contained the Danish version of the ODI, along with the Roland Morris Questionnaire, the LBP Rating Scale, the SF36 (physical function and bodily pain scales) and a global pain rating. At follow-up, a 7-point transition question (TQ) of patient perceived change and a numeric rating scale relating to the importance of the change were included. Responsiveness was operationalised using three strategies: change scores, standardised response means (SRM) and receiver operating characteristic (ROC) analyses. All methods revealed acceptable responsiveness of the ODI in the two patient populations which was comparable to the external instruments. SRM of the ODI change scores at 2 months follow-up was 1.0 for PrS patients and 0.3 for SeS (raw and percentage). A minimum clinically important change (MCID) from baseline score was established at 9 points (71%) for PrS patients and 8 points (27%) for SeS patients using ROC analyses. This was dependable on the baseline entry score with the MCID increasing with 5 points for every 10 points increase in the baseline score. We conclude that the Danish version of the ODI has comparable responsiveness to other commonly used functional status measures and is appropriate for use in low back pain patients receiving conservative care in both the primary and secondary sector. 相似文献
97.
氯胺酮和依托咪酯的BIS50及其对脑电双频指数的影响 总被引:4,自引:0,他引:4
目的 分别测定氯胺酮和依托咪酯诱导时半数患者入睡时的脑电双频指数(BIS)即BIS50和半数有效量(ED50),比较他们对BIS的影响。方法 选择40例无服用精神药物和镇静催眠药、无术前用药的择期手术患者(ASAⅠ~Ⅱ级),随机分为氯胺酮组(K组,n=20)和依托咪酯组(E组,n=20),以半数效量序贯法分别进行氯胺酮和依托咪酯诱导的睡眠观察,以对语言指令不应和睫毛反射消失为入睡指标,同时记录BIS的变化。对取得的数据以直线回归的方法和加权均数法分别求得氯胺酮、依托咪酯的BIS50和ED50。结果 氯胺酮和依托咪酯诱导后,BIS明显下降(P=0.000983),但两者各自BIS下降幅度在入睡与未睡患者之间没有明显差异(P=0.920501和0.956263)。氯胺酮的BIS50和ED50分别是78.81(95%可信区间67.27~97.10)和0.757mg/kg(95%可信区间0.535~1.071mg/kg),依托咪酯的BIS50和ED50分别是60.00(95%可信区间49.74~76.95)和0.089mg,/kg(95%可信区间0.073~0.107mg/kg)。结论 氯胺酮和依托咪酯皆显著降低BIS,但仅凭BIS难以准确预计是否进入睡眠状态。 相似文献
98.
Hy De Lee Euy Young Soh Hoon Sang Chi Byong Ro Kim Kyong Sik Lee Kyung Soon Song Hyun Joo Jung 《Surgery today》1990,20(2):180-185
The relationship between primary tumor proliferative activity and clinical and pathologic characteristics was analyzed in
relation to menopausal status in 32 patients with malignant or benign breast disease. The thymidine labeling index (TLI) showed
significantly higher median values in the cancer patients (3.48 per cent) than in the patients with benign diseases (1.02
per cent). TLI was not significantly affected by delayed incubation at room temperature for about 1 hour. In the breast cancer
patients, TLI did not significantly correlate to tumor size, the presence of axillary lymph node metastasis or pathologic
nuclear grading. The only significant difference was limited to the breast cancer patients without axillary lymph node metastasis
in relation to menopausal status; the TLI in the premenopausal patients (5.10 per cent) was significantly higher (p<0.05)
than that in the postmenopausal patients (2.28 per cent). These data thus suggest that among premenopausal patients without
axillary lymph node metastasis, those with a high TLI could be potential candidates for adjuvant chemotherapy. 相似文献
99.
浙江医科大学附二院门诊处方中精神药物使用调查 总被引:1,自引:0,他引:1
本文对浙江医科大学附属二院1993年7月间31378张合格处方进行统计分析,并用限定日剂量(DDD)和药物使用指数(DUI)为指标,分析镇静催眠药物使用情况。结果表明苯二氮 类药方2067张,占总处方量的6.59%,巴比妥类药方49张,占0.16%,麻醉药方111张;占0.35%。苯二氮 类药方中.女性处方量1202张,男性处方量865张,男、女组间比较有显著性差异。苯二氮 类药方多分布在神经内科,常用的药有舒乐安定和阿普唑仑。九种常用的苯二氮 类药和麻醉性镇痛药的DUI均小于1。提示药物滥用现象少见,该院对这类药物的管理比较严格。麻醉性镇痛药中二氢埃托啡处方占67.57%。 相似文献
100.
L. LEIBOVICI W. R. GRANSDEN S. J. EYKYN H. KONSIBERGER M. DRUCKER S. D. PITLIK I. PHILLIPS 《Journal of internal medicine》1993,234(1):83-89
Abstract. Objectives. To define risk factors associated with bacteraemia caused by Staphylococcus aureus or coagulase-negative staphylococci; and to use them to define patients in need of empiric anti-staphylococcal antibiotic treatment. Design, Derivation set: observational, prospective study; validation set: retrospective analysis of a prospectively collected database. Setting. Derivation set: Beilinson Medical Centre, Petah Tiqva, Israel—a 900-bed university hospital. Validation set: St Thomas's Hospital, London, UK—an 800-bed teaching hospital. Subjects. All episodes of bacteraemia detected at Beilinson Medical Centre between March 1988 and September 1990 (derivation set, n = 1410), and at St Thomas's Hospital during 1987–1990 (validation set, n = 1040). Interventions. None. Main outcome measures. Percentage of staphylococcal bacteraemia in groups of patients defined by the models. Results. The following factors were associated with Staphylococcus aureus bacteraemia: focus of infection (whether high or low risk), haemodialysis, intravenous drug abuse and infection acquired in the orthopaedic ward. A logistic model was used to divide the derivation set into three groups with percentages of Staphylococcus aureus bacteraemia of 1.8%, 13.2% and 33.7% (P < 0.0001); and the validation group 2.5%, 18.2% and 53.2% (P < 0.0001). Factors associated with coagulase-negative staphylococcal bacteraemia were: central or peripheral intravenous catheter as the focus of infection, a preterm neonate, the presence of a central intravenous catheter, low temperature, and a low white blood cell count. A second model including those factors was used to divide the derivation set into three groups with percentages of coagulase-negative staphylococcal bacteraemia of 1.9%, 22.8%, and 43% (P < 0.0001). In the validation set, the percentages were 2.9%, 22.4% and 31.0% (P < 0.001). Conclusions. The present study defines groups at high risk for staphylococcal bloodstream infection, in which empiric treatment should include an anti-staphylococcal drug. 相似文献